Expression of Fra-1 in human hepatocellular carcinoma and its prognostic significance-Reference-Cited by-同舟云学术

Expression of Fra-1 in human hepatocellular carcinoma and its prognostic significance

Published:2017-06 Issue:6 Volume:39 Page:101042831770963
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumour Biol.

Author:

Gao Xiao-Qiang¹,Ge Yong-Sheng¹,Shu Qing-Hua²,Ma Hua-Xing³

Affiliation:

1. Anhui Province Key Laboratory of Hepatopancreatobiliary Surgery and Department of Hepatic Surgery, Anhui Provincial Hospital, Anhui Medical University, Hefei, China

2. Department of General Surgery, Nanjing Second People’s Hospital, Nanjing, China

3. Department of Emergency, The Affiliated Hospital of Guizhou Medical University, Guizhou, China

Publisher

IOS Press

Subject

General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/1010428317709635

Reference42 articles.

1. Hepatocellular Carcinoma

2. Epigenetic mechanisms in hepatocellular carcinoma: How environmental factors influence the epigenome

3. Hepatocellular carcinoma

4. Advanced Hepatocellular Carcinoma: Which Staging Systems Best Predict Prognosis?

5. The leucine repeat motif in Fos protein mediates complex formation with Jun/AP-1 and is required for transformation

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. m6A demethylation of FOSL1 mRNA protects hepatoma cells against necrosis under glucose deprivation;Cell Death & Differentiation;2024-05-18

2. Overexpression of FRA1 (FOSL1) Leads to Global Transcriptional Perturbations, Reduced Cellular Adhesion and Altered Cell Cycle Progression;Cells;2023-09-24

3. FOS-Like Antigen 1 Expression Was Associated With Survival of Hepatocellular Carcinoma Patients;World Journal of Oncology;2023-08

4. MiR-33a targets FOSL1 and EN2 as a clinical prognostic marker for sarcopenia by glioma;Frontiers in Genetics;2022-08-17

5. FRA-1: A key factor regulating signal transduction of tumor cells and a potential target molecule for tumor therapy;Biomedicine & Pharmacotherapy;2022-06